← Eichor
Condition: Herombopag Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Herombopag

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Herombopag Treated T-DM1 Induced Platelet Reduction
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT07257809Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04993885A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06838949Herombopag for Chemotherapy-induced Thrombocytopenia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05236582
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.